Delivery Order SPE2DB20D1110-SPE2DB25FK38D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $47,238.51 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on September 9, 2025, with completion targeted for September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $39,771.86 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 MG tablets (30-count units) under a firm fixed price contract type. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $28,753.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Ondansetron ODT 4mg tablets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of October 9, 2025. The contract is fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) valued at $2,744.16, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The place of performance is the...
- The Defense Logistics Agency awarded a delivery order valued at $6,179.85 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by August 14, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $10,286.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, issued under a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,363.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,629.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $12,168.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract employs firm fixed pricing and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK38DDelivery Order
The Defense Logistics Agency awarded a $9,457.00 delivery order to AmerisourceBergen Drug Corp for 30-count units of Ondansetron ODT 4 mg tablets, with performance in Conshohocken, Pennsylvania and completion by September 4, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. The IDC enables the company to supply a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Ondansetron, an antiemetic medication commonly used in medical settings, represents a routine pharmaceutical supply requirement fulfilled through this established prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 9/3/25 |